The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity

Kitajima, S.; Yoshida, A.; Kohno, S.; Li, F.; Suzuki, S.; Nagatani, N.; Nishimoto, Y.; Sasaki, N.; Muranaka, H.; Wan, Y.; Thai, T. C.; Okahashi, N.; Matsuda, F.; Shimizu, H.; Nishiuchi, T.; Suzuki, Y.; Tominaga, K.; Gotoh, N.; Suzuki, M.; Ewen, M. E.; Barbie, D. A.; Hirose, O.; Tanaka, T.; Takahashi, C.

Published in

Springer Nature [academic journals on nature.com], Oncogene, 36(36), p. 5145-5157, 2017

DOI: 10.1038/onc.2017.124

Tools

Export citation

Search in Google Scholar

The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity

Journal article published in 2017 by S. Kitajima, A. Yoshida, S. Kohno, F. Li, S. Suzuki, N. Nagatani, Y. Nishimoto, N. Sasaki, H. Muranaka, Y. Wan, T. C. Thai, N. Okahashi, F. Matsuda, H. Shimizu, T. Nishiuchi and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity